Verve Therapeutics Inc (VERV)
6.095
-0.07
(-1.14%)
USD |
NASDAQ |
May 08, 16:00
6.095
0.00 (0.00%)
After-Hours: 20:00
Verve Therapeutics Shareholders Equity (Quarterly): 599.50M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 599.50M |
| September 30, 2023 | 460.37M |
| June 30, 2023 | 465.22M |
| March 31, 2023 | 509.48M |
| December 31, 2022 | 550.93M |
| September 30, 2022 | 547.94M |
| June 30, 2022 | 296.33M |
| Date | Value |
|---|---|
| March 31, 2022 | 331.39M |
| December 31, 2021 | 357.35M |
| September 30, 2021 | 384.94M |
| June 30, 2021 | 405.40M |
| March 31, 2021 | -76.43M |
| December 31, 2020 | -63.91M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-76.43M
Minimum
Mar 2021
599.50M
Maximum
Dec 2023
366.81M
Average
405.40M
Median
Jun 2021
Shareholders Equity (Quarterly) Benchmarks
| Acorda Therapeutics Inc | -157.96M |
| Eli Lilly and Co | 12.81B |
| Beam Therapeutics Inc | 981.33M |
| Intellia Therapeutics Inc | 1.050B |
| Gritstone Bio Inc | 51.85M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 752.69M |
| Total Liabilities (Quarterly) | 153.19M |
| Current Ratio | 17.24 |